Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00509951 · ClinicalTrials.gov registry record · NA
Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT00509951: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT00509951 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00509951, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
This study will compare the effectiveness of two types of cognitive behavioral therapy, one-session exposure treatment and family-enhanced one-session exposure treatment, in treating children with specific phobias.
Interventions
- BEHAVIORAL One-session exposure treatment
- BEHAVIORAL Augmented one-session exposure treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-05 |
| Phase | NA |
What the finished NCT00509951 record still lists
NCT00509951 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which One-session exposure treatment is the first listed.
NCT00509951 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00509951 about?
NCT00509951 is a clinical study titled "Parent-Augmented Cognitive Behavioral Therapy to Treat Children With Specific Phobias". This study will compare the effectiveness of two types of cognitive behavioral therapy, one-session exposure treatment and family-enhanced one-session exposure treatment, in treating children with specific phobias.
What is the current status of trial NCT00509951?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2007-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00509951?
The interventions under investigation include: One-session exposure treatment (BEHAVIORAL), Augmented one-session exposure treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00509951?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00509951's enrollment target sits among peer trials
154 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia